Patient Selection For Analgesic Trials To Be Improved Under Public-Private ACTION Initiative

A new collaborative project between FDA and the University of Rochester could help drugmakers salvage pain drugs that have garnered negative clinical trial results but may have efficacy in a narrower population by creating more sensitive assays.